On and Off of Gastric Electrical Stimulation for Refractory Vomiting

Published:December 26, 2019DOI:
      See “Gastric electrical stimulation reduces refractory vomiting in a randomized crossover trial,” Ducrotte P, Coffin B, Bonaz B, et al; ENTERRA research Group, on page 506.
      To read this article in full you will need to make a payment
      AGA Member Login
      Login with your AGA username and password.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • US Food and Drug Administration (FDA)
        Humanitarian device exemption (HDE).
        • Abell T.
        • McCallum R.
        • Hocking M.
        • et al.
        Gastric electrical stimulation for medically refractory gastroparesis.
        Gastroenterology. 2003; 125: 421-428
        • McCallum R.W.
        • Snape W.
        • Brody F.
        • et al.
        Gastric electrical stimulation with Enterra therapy improves symptoms from diabetic gastroparesis in a prospective study.
        Clin Gastroenterol Hepatol. 2010 Nov; 8: 947-954
        • McCallum R.W.
        • Sarosiek I.
        • Parkman H.P.
        • et al.
        Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis.
        Neurogastroenterol Motil. 2013; 25 (815–e636)
        • Stanghellini V.
        Unfulfilled wishes by gastric electrical stimulation.
        Clin Gastroenterol Hepatol. 2011; 9: 447-448
        • Tack J.
        • Janssen P.
        Gastroduodenal motility.
        Curr Opin Gastroenterol. 2010; 26: 647-655
        • Ducrotte P.
        • Coffin B.
        • Bonaz B.
        • et al.
        • ENTERRA research Group
        Gastric electrical stimulation reduces refractory vomiting in a randomized crossover trial.
        Gastroenterology. 2020; 158: 506-514
        • Eypasch E.
        • Williams J.I.
        • Wood-Dauphinee S.
        • et al.
        Gastrointestinal Quality of Life Index: development, validation and application of a new instrument.
        Br J Surg. 1995; 82: 216-222
        • Aziz I.
        • Palsson O.S.
        • Whitehead W.E.
        • et al.
        Epidemiology, clinical characteristics, and associations for Rome IV functional nausea and vomiting disorders in adults.
        Clin Gastroenterol Hepatol. 2019; 17: 878-886
        • Jones M.P.
        • Talley N.J.
        • Eslick G.D.
        • et al.
        Community subgroups in dyspepsia and their association with weight loss.
        Am J Gastroenterol. 2008; 103: 2051-2060
        • Piessevaux H.
        • De Winter B.
        • Louis E.
        • et al.
        Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings.
        Neurogastroenterol Motil. 2009; 21: 378-388
        • Tack J.
        • Jones M.P.
        • Karamanolis G.
        • et al.
        Symptom pattern and pathophysiological correlates of weight loss in tertiary-referred functional dyspepsia.
        Neurogastroenterol Motil. 2010; 22 (e4–5): 29-35
        • Tack J.
        • Ly H.G.
        • Carbone F.
        • et al.
        Efficacy of mirtazapine in patients with functional dyspepsia and weight loss.
        Clin Gastroenterol Hepatol. 2016; 14: 385-392.e4
        • Carbone F.
        • Van den Houte K.
        • Clevers E.
        • et al.
        Prucalopride in gastroparesis: a randomized placebo-controlled crossover study.
        Am J Gastroenterol. 2019; 114: 1265-1274
        • Pasricha P.J.
        • Yates K.P.
        • Sarosiek I.
        • et al.
        • NIDDK Gastroparesis Clinical Research Consortium (GpCRC)
        Aprepitant has mixed effects on nausea and reduces other symptoms in patients with gastroparesis and related disorders.
        Gastroenterology. 2018; 154: 65-76.e11
        • Ayinala S.
        • Batista O.
        • Goyal A.
        • et al.
        Temporary gastric electrical stimulation with orally or PEG-placed electrodes in patients with drug refractory gastroparesis.
        Gastrointest Endosc. 2005; 61: 455-461
        • Andersson S.
        • Ringström G.
        • Elfvin A.
        • et al.
        Temporary percutaneous gastric electrical stimulation: a novel technique tested in patients with non-established indications for gastric electrical stimulation.
        Digestion. 2011; 83: 3-12
        • Abell T.L.
        • Johnson W.D.
        • Kedar A.
        • et al.
        A double-masked, randomized, placebo-controlled trial of temporary endoscopic mucosal gastric electrical stimulation for gastroparesis.
        Gastrointest Endosc. 2011; 74: 496-503.e3

      Linked Article